Intervention

None intervention

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions5

Lead sponsors shown3

Clinical trials

3 shown

Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic TumorsNCT05683353 · 2022-12-14

ACTIVE_NOT_RECRUITING

Breast Cancer and Kinesiophobia and Physical ActivityNCT05090098 · 2021-08-01

Study of the Influence of Ductal Carcinoma in Situ on the Outcome of Invasive Breast CancerNCT03669952 · 2010-01-01

Common conditions

Breast Cancer1 Hematologic Malignancy1 Kinesiophobia1 Outcome of Breast Cancer1 SARS-CoV-2 Infection1

Leading sponsors

Acibadem University1 Omphis Foundation1 Peking University First Hospital1

Trial status mix

COMPLETED2

ACTIVE_NOT_RECRUITING1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.